Skip to main content
. 2022 Apr 1;13:843088. doi: 10.3389/fpsyt.2022.843088

Table 2.

A comparison of first choice treatment options for neuropsychiatric symptoms between centers for cognitive disorders and dementia (CDCD) and other settings.

Anti-depressants Atypical antipsychotics Typical antipsychotics Benzo-diazepines Anti-epileptics Dopaminergics Non-pharmacological interventions
Aggression CDCD 1.5 83.7 6.9 2.9 2.9 - -
Others 4 81.5 8.2 2 4 - -
Agitation CDCD 15.1 64 5.5 1.4 8.2 - -
Others 17.7 64.2 8 1.9 10.2 - -
Anxiety CDCD 57.5 14.5 3.1 18.3 18.4 - -
Others 51 22.6 4.2 15.4 8.2 - -
Apathy CDCD 92.2 - - - - 4.5 -
Others 85.3 - - - - 9.1 -
Depression CDCD 86.7 13 1.5 - - - -
Others 83 6.4 2 4.4 2.1 - -
Nutrition disorders CDCD 14.7 16.2 3.1 1.5 - - 61.6
Others 18.9 18.4 - 0 - - 60
Psychosis CDCD 5.6 84.4 8.5 - - - -
Others 3.9 81.8 9.6 1.9 6 - -
Sleep disorders CDCD 12.6 13 1.5 9.9 - - 68.1
Others 11.3 23.1 0 13.2 - - 59.6

Data are expressed as percentages (CDCD: n. 79; other settings: n. 57). Bold values indicate the first choices.